A crucial ‘on switch’ that boosts the body’s defences against infections has been successfully identified in new scientific research.
The breakthrough made by researchers at the University of Aberdeen and the University of Dundee could lead to the development of new drugs to enhance the body’s immune responses to attack, which could benefit people suffering from cancer and other serious conditions.
Their findings have been published in the Journal of Molecular and Cell Biology.
“We have shown that the cells which turn on our immune responses to defend against, for example, infectious diseases, require a particular protein to activate them in order to function properly,” explains Dr Martin-Granados formerly of the University of Aberdeen and now at Cambridge.
“This protein, or enzyme, (PTP1B) effectively acts as a kind of ‘on switch’ and if it is missing or dysfunctional in our body, we cannot mount effective immune responses to tumours or infections.”
The paper describes the fine tuning of cell signals which orchestrate our immune defences, for instance when we are vaccinated against infections.
Dr Alan Prescott from the University of Dundee adds: “The key switch molecule PTP1B allows the uninterrupted production of something called podosomes (which behave like feet for the cell). The cells that turn on our immune systems (dendritic cells) use these “mini-feet” to move though tissue and “home in” on a type of white blood cell called a T cell, which are essential for clearing viruses from our system. These are located at the “glands”, such as those in our neck, which become enlarged when patients get throat infections, for example.
Read more: Immune system ‘on switch’ breakthrough could lead to new targeted drugs
The Latest on: Immune on switch
[google_news title=”” keyword=”immune on switch” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immune on switch
- Ocrevus best to prevent MS relapses after stopping Tysabri: Studyon June 8, 2023 at 9:59 pm
IV Ocrevus was seen to work better than oral therapies Gilenya or Tecfidera for preventing relapses in MS patients who stopped using Tysabri.
- Smoke from wildfires, a fact of life in the West, catches outdoor workers off guard in the Easton June 8, 2023 at 3:32 pm
The hazardous haze from Canada’s wildfires is taking its toll on outdoor workers along the Eastern U.S. who carried on with their daily jobs even as dystopian orange skies forced the cancelation of ...
- The Brain's Immune Cells Can Drive Anxietyon June 8, 2023 at 12:57 am
Scientists discovered insights into the importance of a minor cell type in the brain—microglia—in controlling anxiety-related behaviors in laboratory mice.
- Switch to Plant-Based Diet Could Boost Prostate Cancer Survivalon June 7, 2023 at 2:32 pm
Following a healthy plant-based diet after a diagnosis of prostate cancer may help prevent the disease from progressing or recurring, a new study suggests. Men who ate a diet rich in fruits, ...
- Underreported? Untreated? New CDC study sheds light on Lyme disease, impactson June 5, 2023 at 3:04 am
Most patients who get Lyme disease are treated with antibiotics and quickly recover, the study notes. But many others have long-term symptoms.
- This is exactly how to switch off even when you feel likely you've tried *everything*, according to the expertson June 2, 2023 at 10:01 pm
Time and time again, studies have shown that one of the simplest self care ideas and ways to switch off is treating yourself to some downtime. What that looks like will be different for everyone - for ...
- Game-changing gene found in animal study could switch off cancer for lifeon May 29, 2023 at 1:52 pm
Researchers have identified a potential game-changer in the quest for more effective cancer treatments. A study – which was published in the Proceedings of the National Academy of Sciences – focuses ...
- What Sleepwalking Teaches Us About Trauma's Effects on the Brainon May 25, 2023 at 4:00 am
Sleepwalking shows us that a person's consciousness is not one dimensional. Rather, it has many unique flavors, writes .
- The Global Gene Switch Market is anticipated to grow at a CAGR of 11.5%, till 2035, claims Roots Analysison May 23, 2023 at 7:45 am
Roots Analysis has announced the addition of "Gene Switch Market, 2023-2035" report to its list of offerings. Given the rising demand for ...
- Nintendo Switch denied a price cut even after six yearson May 12, 2023 at 7:50 am
You would think the Nintendo Switch would have seen some kind of price cut by now, considering it’s been widely available for over six year. However, Nintendo’s never been one for making its products ...
via Bing News